Nurix Therapeutics to Present Preclinical Data at Upcoming 5th Medicinal Chemistry & Protein Degradation Summit and 62nd ASH Annual Meeting and ExpositionGlobeNewsWire • 11/04/20
Nurix Therapeutics Announces Appointment of Robert Tjian as Chairman of Scientific Advisory Board and His Resignation from the Board of DirectorsGlobeNewsWire • 10/26/20
Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 10/14/20
Nurix Therapeutics to Present at 3rd Annual Targeted Protein Degradation SummitGlobeNewsWire • 10/06/20